Report Description

India valsartan market is expected to grow at a formidable rate during the forecast period. The India valsartan market is driven by the growing geriatric population in the country susceptible to various chronic diseases such as cardiovascular diseases including heart failure, myocardial infarction, hypertension, diabetes, among others. This has drastically increased the patient pool. This in turn is expected to positively influence the market growth through FY2026. Additionally, valsartan also reduces hospitalizations in patient with heart failures thereby fueling the market growth over the next few years.

The India valsartan market is segmented based on source, form, distribution channel, application, end user, company and region. Based on source, the market can be split in in-house and contract manufacturing organizations. The contract manufacturing organizations segment is expected to witness significant growth during the forecast period on account of the increasing outsourcing being done by the major pharmaceutical companies for the manufacturing of APIs and drugs so that they can focus on their R&D activities and expansion plans. Additionally, these organizations have the capability to produce and provide bulk quantities of formulation to their clients at affordable prices and in lesser time.

The major players operating in the India valsartan market are Jubilant Pharma Ltd., Aurobindo Pharma Ltd., Sun Pharmaceuticals Industries Ltd., Amneal Pharmaceuticals Pvt. Ltd., Torrent Pharmaceutical Ltd., Unichem Laboratories Ltd., Novartis India Ltd., Dr. Reddy’s Laboratories Ltd., Teva Pharmaceuticals Industries Ltd., Lupin Pharmaceuticals Ltd. and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India valsartan market from FY2016 to FY2019.
  • To estimate and forecast the market size of India valsartan market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India valsartan market based on source, form, distribution channel, application, end user, company and regional distribution.
  • To identify dominant region or segment in the India valsartan market.
  • To identify drivers and challenges for India valsartan market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India valsartan market.
  • To identify and analyze the profile of leading players operating in India valsartan market.
  • To identify key sustainable strategies adopted by market players in India valsartan market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India valsartan market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Valsartan manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to valsartan

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India valsartan market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Valsartan Market, By Source:
    • In-House
    • Contract Manufacturing Organizations
  • India Valsartan Market, By Form:
    • Tablet
    • Capsule
    • Solution
    • Others
  • India Valsartan Market, By Distribution Channel:
    • Online
    • Offline
  • India Valsartan Market, By Application:
    • Hypertension
    • Heart Failure
    • Myocardial Infarction
    • Others
  • India Valsartan Market, By End User:
    • Adult
    • Pediatric
  • India Valsartan Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India valsartan market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India Valsartan market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Valsartan Market

4.    Executive Summary

5.    Manufacturing Valsartan

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Valsartan

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Valsartan Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.2.     By Form (Tablet, Capsule, Solution, Others)

7.2.3.     By Distribution Channel (Online v/s Offline)

7.2.4.     By Application (Hypertension, Heart Failure, Myocardial Infarction, Others)

7.2.5.     By End User (Adult v/s Pediatric)

7.2.6.     By Region (North, East, South, West)

7.2.7.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Jubilant Pharma Ltd.      Company Brief      Production Plants & Capacity (If Available)      Financials (If Available)      Captive Consumption Vs Merchant Sale      Current & Future Plans

14.1.2.  Aurobindo Pharma Ltd.

14.1.3.  Sun Pharmaceuticals Industries Ltd.

14.1.4.  Amneal Pharmaceuticals Pvt. Ltd.

14.1.5.  Torrent Pharmaceutical Ltd.

14.1.6.  Unichem Laboratories Ltd.

14.1.7.  Novartis India Ltd.

14.1.8.  Dr. Reddy’s Laboratories Ltd.

14.1.9.  Teva Pharmaceuticals Industries Ltd.

14.1.10.                Lupin Pharmaceuticals Ltd.

15.  Strategic Recommendations

16.  About Us & Disclaimer 

Figures and Tables

Frequently asked questions